EVMN
Financials
- Market Capitalization 493.21 M
- Employee 48
- Founded 2020
- CEO N/A
- Website www.evommune.com
- Headquarter Delaware, United States
- FIGI BBG00Y79N887
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2919 |  CCCC C4 Therapeutics, Inc. - Common Stock | 4.10 USD | -3.30% | +3.02% | +18.84% | +62.06% | 504.40 M USD | ||
| 2931 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 6.21 USD | -2.05% | -5.77% | +33.84% | +381.40% | 495.58 M USD | ||
| 2948 |  PRTA Prothena Corporation plc - Ordinary Shares | 9.38 USD | +3.19% | +1.08% | +8.56% | +13.42% | 481.54 M USD | ||
| 2951 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 4.51 USD | -0.22% | -0.88% | -13.77% | +443.37% | 481.08 M USD |
Frequently asked questions about Evommune, Inc.
What is the Evommune, Inc. stock price today?
The current price of Evommune, Inc. (EVMN) is 13.59. Over the past 24 hours, the stock has changed by +1.19%. Follow the EVMN chart for real-time price dynamics.
What is the stock ticker of Evommune, Inc.?
Evommune, Inc. trades under the ticker EVMN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Evommune, Inc. stock going up?
EVMN has changed by -3.69% over the last week, +22.32% over the last month, and -21.54% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Evommune, Inc.?
Evommune, Inc. currently has a market capitalization of 493.21 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Evommune, Inc. earnings last quarter?
Last quarter, Evommune, Inc. reported earnings of -0.89 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Evommune, Inc. revenue for the last quarter?
Evommune, Inc. reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Evommune, Inc. net income for the last quarter?
Evommune, Inc. reported net income of -32.25 M for the last quarter. The previous quarter showed -21.67 M, which means net income changed by -48.78%.
How many employees does Evommune, Inc. have?
As of the latest available data, Evommune, Inc. has 48 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Evommune, Inc. stock?
You can buy Evommune, Inc. (EVMN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Evommune, Inc. stock?
Investing in Evommune, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EVMN chart and related analysis on metatrader.com as part of your research.